A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 1, 2007, Pages 204-210

  Kim, Nam Kyu ^a,b   Baik, Seung Hyuk ^a,b   Min, Byung Soh ^a,b   Pyo, Hong Ryull ^d   Choi, Yun Jung ^c   Kim, Hogeun ^a,b   Seong, Jinsil ^a,b   Keum, Ki Chang ^a,b   Rha, Sun Young ^b   Chung, Hyun Cheol ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

Histopathologic downstaging; Preoperative chemoradiotherapy; Rectal cancer; Tumor regression grade; Tumor volume

Indexed keywords

CHEMOTHERAPY; HISTOLOGY; PATHOLOGY; PATIENT TREATMENT; RADIOTHERAPY; VOLUMETRIC ANALYSIS;

HISTOPATHOLOGIC DOWNSTAGING; PREOPERATIVE CHEMORADIOTHERAPY; RECTAL CANCER; TUMOR REGRESSION GRADE; TUMOR VOLUME;

ONCOLOGY;

FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BOLUS INJECTION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; REMISSION INDUCTION; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY;

EID: 33845663185     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.020     Document Type: Article

References (28)

1. Janjan N.A., Crane C., Feig B.W., et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24 (2001) 107-112
2. Janjan N.A., Khoo V.S., Abbruzzese J., et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44 (1999) 1027-1038
3. Valentini V., Coco C., Cellini N., et al. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int J Radiat Oncol Biol Phys 40 (1998) 1067-1075
4. Adell G., Sun X.F., Stal O., et al. p53 status: An indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 51 (1999) 169-174
5. Tannapfel A., Nusslein S., Fietkau R., et al. Apoptosis, proliferation, bax, bcl-2, and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 41 (1998) 585-591
6. Berger C., de Muret A., Garaud P., et al. Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications. Int J Radiat Oncol Biol Phys 37 (1997) 619-627
7. Onaitis M.W., Noone R.B., Fields R., et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 8 (2001) 801-806
8. Onaitis M.W., Noone R.B., Hartwig M., et al. Neoadjuvant chemoradiation for rectal cancer: Analysis of clinical outcomes from a 13-year institutional experience. Ann Surg 233 (2001) 778-785
9. Chau I., Allen M., Cunningham D., et al. Neoadjuvant systemic fluorouracil and mitomycin C prior to synchronous chemoradiation is an effective strategy in locally advanced rectal cancer. Br J Cancer 88 (2003) 1017-1024
10. Valentini V., Coco C., Picciocchi A., et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer?. A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53 (2002) 664-674
11. Minsky B.D., Cohen A.M., Enker W.E., et al. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer. Int J Radiat Oncol Biol Phys 37 (1997) 289-295
12. Green F., Page D., and Fleming I. AJCC cancer staging manual. 6th ed. (2002), Springer, New York
13. Ryan R., Gibbons D., Hyland J.M., et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 47 (2005) 141-146
14. Kim Y.H., Kim D.Y., Kim T.H., et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 761-768
15. Willett C.G., Warland G., Coen J., et al. Rectal cancer: The influence of tumor proliferation on response to preoperative irradiation. Int J Radiat Oncol Biol Phys 32 (1995) 57-61
16. Chapet O., Romestaing P., Mornex F., et al. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?. Int J Radiat Oncol Biol Phys 61 (2005) 1371-1377
17. Kim N.K., Baek S.H., Seong J.S., et al. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor specific mesorectal excision for fixed localized rectal cancer: Impact of post-irradiated pathologic downstaging on local recurrence and survival. Ann Surg (2006) In press
18. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann Surg 240 (2004) 711-718
19. Rodel C., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
20. Hiotis S.P., Weber S.M., Cohen A.M., et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. J Am Coll Surg 194 (2002) 131-135 discussion 135-136
21. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 (1994) 2680-2686
22. Ruo L., Tickoo S., Klimstra D.S., et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 236 (2002) 75-81
23. Crane C.H., Skibber J.M., Feig B.W., et al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97 (2003) 517-524
24. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12 (1997) 19-23
25. Wheeler J.M., Warren B.F., Mortensen N.J., et al. Quantification of histologic regression of rectal cancer after irradiation: A proposal for a modified staging system. Dis Colon Rectum 45 (2002) 1051-1056
26. Metha V.K., Cho C., Ford J.M., et al. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55 (2003) 132-137
27. Paoli A.D., Chiara S., Luppi G., et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable rectal cancer: A multicentric phase II study. Ann Oncol 17 (2006) 246-251
28. Kim J.S., Kim J.S., Cho M.J., et al. Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 54 (2002) 403-408